Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Q4 2024 Hercules Capital Inc Earnings Call

In This Article:

Participants

Michael Hara; Investor Relations; Hercules Capital Inc

Scott Bluestein; President, Chief Executive Officer, Chief Investment Officer, Director; Hercules Capital Inc

Seth Meyer; Chief Financial Officer; Hercules Capital Inc

Brian Mckenna; Analyst; Citizens JMP Securities LLC

Crispin Love; Analyst; Piper Sandler

Finian O'Shea; Analyst; Wells Fargo Securities LLC

John Hecht; Analyst; Jefferies

Christopher Nolan; Analyst; Ladenburg Thalmann & Co

Paul Johnson; Analyst; Keefe, Bruyette & Woods, Inc.

Presentation

Operator

Hello, and welcome, everyone, to the Hercules Capital fourth quarter and full year 2024 financial results. (Operator Instructions) Please be advised that today's conference is being recorded.
Now it's my pleasure to turn the call over to the Senior Director, Investor Relations and Corporate Communications, Michael Hara. Please proceed.

Michael Hara

Thank you, Carmen. Good afternoon, everyone, and welcome to Hercules conference call for the fourth quarter and full year 2024. With us on the call today from Hercules are Scott Bluestein, CEO and Chief Investment Officer; and Seth Meyer, CFO.
Hercules' financial results were released just after today's market closed and can be accessed from Hercules' Investor Relations section at investor.htgc.com. An archived webcast replay will be available on the Investor Relations web page for at least 30 days following the conference call.
During this call, we may make forward-looking statements based on our own assumptions and current expectations. These forward-looking statements are not guarantees of future performance and should not be relied upon in making any investment decision.
Actual financial results may differ from the forward-looking statements made during this call for a number of reasons, including, but not limited to, the risks identified in our annual report on Form 10-K and other filings that are publicly available on the SEC's website. Any forward-looking statements made during this call are made only as of today's date, and Hercules assumes no obligation to update any such statements in the future.
And with that, I'll turn the call over to Scott.

Scott Bluestein

Thank you, Michael, and thank you all for joining the Hercules Capital Q4 and Full Year 2024 Earnings Call. 2024 was another year of record operating performance and solid controlled growth for Hercules Capital. We were able to set several new financial and performance records and demonstrate strong platform growth while managing the business and balance sheet conservatively.
Our performance in 2024 was highlighted by a record total investment income, record net investment income and record total gross fundings, all of which put us in position to once again declare a new supplemental distribution program for our shareholders. Driven by the growth of both the BDC and our private credit funds business, Hercules Capital is now managing approximately $4.8 billion of assets, an increase of more than 14% from where we were at year-end 2023.
Hercules Capital achieved a significant milestone in 2024 as we celebrated 20 years of investment activity, in which our investment platform reached and surpassed the $20 billion mark in cumulative debt commitments since inception. This achievement underscores our commitment to serving the capital needs of the venture and growth-stage ecosystems.
Our success since inception has been made possible by the tremendous work and dedication of our talented employees and the trust that our borrowers and their investors have placed with us. Our unwavering commitment to venture and growth-stage companies and our continuous focus on always doing what we believe is in the best interest of our shareholders and stakeholders has served us incredibly well for the last 20 years and will help guide us going forward.
Let me recap some of the highlights and achievements for 2024. Record full year 2024 total gross fundings of $1.81 billion, an increase of 13% year-over-year. Record full year 2024 total investment income of $493.6 million, an increase of 7.1% year-over-year. Record full year 2024 net investment income of $325.8 million, an increase of 7.2% year-over-year. Annual ROAE of 17.2% and ROAA of 7.3%.
Strong net debt portfolio growth of $457 million, which excludes the portfolio growth of our private funds business. Total platform AUM of approximately $4.8 billion, an increase of more than 14% year-over-year. Consistent and growing quarterly dividends from our RIA, which generated $6.8 million in dividend income for the company in 2024, received SBA approval for our fourth SBIC license, and we now manage 2 active SBA funds.
Reaffirmed investment-grade ratings from our four rating agencies, Fitch, KBRA, Moody's and Morningstar DBRS. And 5 consecutive years of delivering supplemental distributions to our shareholders.
As we enter 2025, we continue to expect higher-than-normal market and macro volatility, given the change in administration and the ongoing changes taking place in the global geopolitical environment. At the same time, we anticipate a more favorable new business landscape broadly, and particularly for certain growth-stage companies and sectors.
Our expectation is that we will see more M&A, more capital markets activity and more support for technology-oriented businesses in 2025. And we are already seeing this come to fruition in Q1.
We intend to continue to manage our business and balance sheet defensively, while maintaining maximum flexibility to take advantage of market opportunities. This includes continuing to enhance our liquidity position, further tightening our credit screens for new underwritings and maintaining our higher-than-normal first lien exposure, which was at 91% in Q4 compared to 89.5% in Q3.
With GAAP leverage under 90%, over $1.1 billion of liquidity across the platform and no material near-term debt maturities, we believe that we are incredibly well positioned to benefit from a more favorable originations market in 2025 and that this will be a key differentiator of our business this year.
Q4 is seasonally one of the stronger quarters in terms of equity capital investments and overall market activity across the venture and growth-stage ecosystem. And this year was no different. The venture and growth-stage markets finished strong with respect to venture capital investment activity and venture capital M&A exit activity. This strength was reflected in our total debt and equity commitments as well as our fundings in the fourth quarter.
Let me now recap some of the key highlights of our performance for Q4. In Q4, we originated total gross debt and equity commitments of over $619 million and gross fundings of over $468 million. For the year, we committed nearly $2.7 billion of capital and delivered record funding performance of approximately $1.81 billion.
As a result, we generated total investment income of $121.8 million and net investment income of $81.1 million or $0.49 per share. We were able to achieve 123% coverage of our quarterly base distribution of $0.40 per share despite ending the quarter with very conservative GAAP leverage of 89.6%.
We expect to slowly bring leverage up throughout 2025, which we believe will help partially offset further potential declines in base rates and some of the spread compression that we have seen over the last several quarters on new originations. Having an abundance of available liquidity to drive net debt portfolio growth near term while utilizing lower-than-normal leverage, provides us with a distinct competitive advantage in this regard.
This is our seventh consecutive quarter of over $100 million of quarterly core income, which excludes the benefit of prepayment fees or fee accelerations from early repayments. This puts us in a very solid position to be able to continue to comfortably cover our quarterly base distribution in the current rate environment. We generated a return on equity in Q4 of 17%, and our portfolio generated a GAAP effective yield of 13.7% in Q4 and a core yield of 12.9%.
Core yields declined from 13.3% in Q3, largely coming from declining base rates and some spread compression on new originations. As of the end of the year, approximately 50% of our portfolio has already reached the contractual floor on rates.
Our balance sheet with conservative leverage and low cost of leverage remains very well positioned to support our continued growth objectives and provides us with the ability to continue to focus on quality originations instead of chasing higher-yielding assets, which we believe have more risk.
The focus of our origination efforts in Q4 was on maintaining a disciplined approach to capital deployment with an emphasis on diversification. Our Q4 originations activity was driven by both our technology and life sciences teams. In Q4, approximately 67% of our fundings were to technology companies, while approximately 42% of our new commitments were to life sciences companies.
We funded debt capital to 30 different companies in Q4, of which nine were new borrower relationships. For the year, we funded capital to 72 different companies, of which 32 were new borrower relationships. This is reflective of our balanced approach during the quarter to focus on select, high-quality new originations and prioritize capital deployment within the portfolio, where we know the credit quality and performance history of the underlying borrowers.
We also increased our capital commitments to several portfolio companies during the quarter, which speaks to our unique ability to scale alongside our borrowers as they grow their businesses. Our available unfunded commitments decreased to approximately $448.5 million from 48 -- sorry, from $489 million in Q3. The momentum that we saw on originations in Q4 has continued and accelerated in Q1.
Since the close of Q4 and as of February 10, 2025, our deal teams have closed $250.2 million of new commitments and funded $201.3 million. We have pending commitments of an additional $578.5 million in signed, nonbinding term sheets, and we expect this number to continue to grow as we progress in Q1.
Given the market backdrop throughout much of 2024, we are pleased with the exit activity that we saw in our portfolio during the year. In Q4, we had 4 M&A events in our portfolio which included one life sciences portfolio company and three technology portfolio companies announcing acquisitions. For the year, we had 13 portfolio companies announced or complete an M&A event. So our exit activity remained healthy in 2024. Post year-end, we had one portfolio company confidentially filed for an IPO.
Early loan repayments decreased slightly in Q4 to approximately $225 million, which was within our guidance of $150 million to $250 million. Approximately 40% of our Q4 prepayments were attributable to M&A events or equity capital events, which we view as a positive signal overall. For Q1 2025, we expect prepayments to be in the range of $100 million to $200 million, although this could change as we progress in the quarter.
Credit quality of the debt investment portfolio remained stable quarter-over-quarter. Our weighted average internal credit rating of 2.26 increased slightly from the 2.24 rating in Q3 and remains at the lower end of our normal historical range.
Our Grade 1 and 2 credits increased slightly to 65.9% compared to 65.2% in Q3. Grade 3 credits decreased modestly to 29% in Q4 versus 31.9% in Q3. Our rated 4 credits increased to 4.6% from 2.3% in Q3, and our rated 5 credits decreased to 0.5%.
In Q4, the number of loans and companies on nonaccrual decreased by one. We had one debt investment on nonaccrual with an investment cost and fair value of approximately $61.3 million and $18.2 million, respectively, or 1.7% and 0.5% as a percentage of our total investment portfolio at cost and fair value, respectively.
With respect to our broader credit book and outlook, we generally remain pleased by what we are seeing on a portfolio level, and our portfolio monitoring remains enhanced. We have noted a noticeable shift in how certain venture capital investors are approaching the current market for new investments, with much more of a focus and emphasis on valuation and less of an emphasis on capital deployment broadly.
This is something that we are watching closely as companies that raised equity capital over the last 24 to 36 months at arguably inflated valuations may struggle to raise new money from new investors in the current market. This will likely test current syndicates in terms of their ability and willingness to continue to support their own existing current portfolio companies.
During Q4 2024, Hercules had net realized losses of $33.5 million, comprised of gross realized gains of $21.9 million, primarily due to the gain on equity investments, offset by $55.4 million of losses. The losses were due to $53.9 million from the write-off of two debt investments, $1.3 million from losses on equity and warrant investments and $0.2 million from realized losses on debt extinguishment.
$41.9 million out of the $53.9 million was already recognized as an unrealized loss in 2023 and therefore, did not have any impact on net asset value. Our net asset value per share in Q4 was $11.66, an increase of 2.3% from Q3 2024.
We ended Q4 with strong liquidity of $658.8 million in the BDC and over $1.1 billion of liquidity across the platform. Our balance sheet with healthy liquidity, a low cost of debt relative to our peers and 4 investment-grade credit ratings continues to position us well and afford us the ability to compete aggressively on quality transactions.
As discussed earlier, we saw a significant improvement in the venture capital ecosystem during Q4. Venture capital investment activity of $209 billion for 2024 increased 29% from 2023, according to data gathered by PitchBook-NVCA.
In Q4, venture capital investment activity was $74.6 billion, rebounding from the lower levels that we saw in Q3 and discussed on last quarter's call. Fundraising activity finished 2024 at $76.1 billion. M&A exit activity for U.S. venture capital-backed companies finished at $82.6 billion, an increase of 27% from 2023. IPO activity remained muted, with fewer companies going public, but raising more dollars.
We believe that the ecosystem will remain healthy and that the recent numbers reflect a continued reversion back to the historical pre-COVID norm. Consistent with the aggregate data for the ecosystem during Q4, capital raising across our portfolio increased from Q3, with 18 companies raising approximately $961 million in new capital, up from $704 million raised in the prior quarter.
For the year, we had 66 portfolio companies raise over $6 billion of new capital, which was higher than the amount of equity capital in a number of portfolio companies raising new capital in 2023. Quarter-to-date in Q1, our portfolio companies have already raised over $1.2 billion of new capital, which speaks to some of the overall market momentum that we are seeing.
Given our strong operating performance in 2024, we exited Q4 with undistributed earnings spillover increasing to over $163 million or $0.96 per ending shares outstanding. For Q4, we are maintaining our quarterly base distribution of $0.40, and we declared a new supplemental distribution of $0.28 for 2025, which will be distributed equally over the next 4 quarters, or $0.07 per share per quarter for a total of $0.47 of shareholder distributions each quarter.
This is our fifth consecutive year of being able to provide our shareholders, with a supplemental distribution on top of our regular quarterly base distribution. In closing, our scale, institutionalized lending platform and our ability to capitalize on a rapidly changing competitive and macro environment continues to drive our business forward and our operating performance to record levels.
In Q4, Hercules delivered its seventh consecutive quarter of over $100 million of quarterly core income, which again excludes the benefit of prepayment fees or fee accelerations from early prepayments.
Our continued success is attributable to the tremendous dedication, efforts and capabilities of our 100-plus employees and the trust that our venture capital and private equity partners place with us every day. We are thankful to the many companies, management teams, and investors that continue to make Hercules their partner of choice.
I will now turn the call over to Seth.